People

Grant Kardachi AM, (Chair)
Grant is a former national President of PSA, Past Chair of AACP, and has chaired many national and state sub-committees. He is currently Chair of PRASA and a board member of AACP and Southern Cross Care having recently retired from the PSA National Board. He has also served on the South Australian Domiciliary Medication Management Review Implementation Committee and served on SA diabetes and asthma committees. A Fellow and Life Member of the PSA, he was awarded the Barry Schultz Medal for Excellence in Pharmacy by the Pharmacy Guild of Australia in 2013. Grant was a community pharmacist owner for many years, and he views practice change as an important foundation to integrate new initiatives into a pharmacy model that is sustainable and viable in the future to ensure patients have the best possible health outcomes.

Professor Andrew Somogyi
Andrew is Professor in Clinical and Experimental Pharmacology at The University of Adelaide. He is a practicing pharmacist and teaches into medical, dental, nursing and several health science courses. He was a member of several TGA advisory committees and is a SA Health advisory committee member. He has an international research track record in pharmacogenetics and genomics, is chair of national and international pharmacogenetics committees and contributes to international pharmacogenetics guideline implementation consortia. He is a fellow of the British Pharmacological Society, the Royal Society of Medicine, and Faculty of Pain Medicine (Australian and New Zealand College of Anaesthetists). He is a former president and secretary of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists

Professor Nigel Stocks
Nigel is Head of the Discipline of General Practice at the University of Adelaide and Director of the only national Primary Care Committee and deputy chair of the Vaccine Preventable Disease Advisory Group for SA. He is an experienced primary health care researcher who has conducted large and small RCT’s in general practice but also with an interest in qualitative and health services research. His main areas of interest include cardiovascular and infectious disease, prevention and quality of life. For several years he was the RACGP SA/NT Faculty Chair, a member and Chair of their national Council and member of their research committee.

Professor Carl Kirkpatrick
Carl is a Professor of Pharmacy Practice at the Monash Institute of Pharmaceutical Sciences, Monash University. He has an international track record in the application of quantitative clinical pharmacology for drug development and optimising older medications, as well as extensive experience in pharmacy education, including the development of guidelines and educational content for healthcare professionals. He is currently the immediate past president of the Australian Society of Clinical and Experimental Pharmacologists and Toxicologists.

Andrew Sluggett
Andrew is Chief Pharmacist and General Manager of CPIE Pharmacy Services. Andrew is a Director on the PSA National Board and is a longstanding member of the PSA (SA/NT) Branch Committee, being Co-vice president since 2014. Andrew received the PSA (SA/NT) Pharmacist of the Year Award in 2014. He has acquired a broad range of skills and experience in both public hospital and community settings, including as a clinical pharmacist, accredited pharmacist, and cytotoxic/sterile compounding pharmacist. Andrew holds a BSc (Hons) in Pharmacology. He also has a strong focus on transitions of care and Hospital in the Home (HITH).

Paul Wappett
Paul became CEO of the Royal Australian College of General Practitioners (RACGP) in October 2021. A lawyer by profession, Paul's previous positions have included being the CEO of Open Universities Australia, CEO of the Australian Institute of Business and legal and commercial roles at CPA Australia, the Western Bulldogs Football Club, Mobil Oil Australia, and law firm Clayton Utz. Paul has led substantial organisational transformations throughout his career, leading organisations to adapt to changes in their external environments, to build organisational cultures that enable them to improve performance, to enable them to effectively interact with complex groups of stakeholders, and to redesign the way in which they transact with and relate to their customers/students/members, particularly digitally. He is currently a non-Executive director of Phoenix Australia, Australia’s national centre of excellence in post-traumatic mental health. Previous roles include being the non-Executive Chair of Berry Street, the largest child protection agency in Victoria, the Executive Chair of corporate training company e3 Learning, and a non-Executive director of edtech start-up Aeyons Pty Ltd.